Home
QuartzBio

QuartzBio Market Share Analysis for August 2026

Find answers to the most frequently asked questions about QuartzBio, our platform, and our Sample and Biomarker Intelligence Solutions.

Industry: N/A

Domainquartz.bio

Year Founded2012

Employees51 - 200

Annual Revenue$200M - $500M

QuartzBio

QuartzBio (including company regionals)

quartz.bio

See more website traffic and engagement information

QuartzBio Revenue up to August 2026 is 200M - 500M

revenue generated by QuartzBio top domains

QuartzBio top domains revenue over 3 years

Revenue for QuartzBio top domains

quartz.bio200M - 500M

See more with Sales Intelligence

Total visits to QuartzBio's top domains

Understand QuartzBio market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

quartz.bio3K

See more with Sales Intelligence

Avg. visit duration in QuartzBio's top domains

Analyze QuartzBio engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

quartz.bio00:00:01

See more with Sales Intelligence

Avg. pageviews on QuartzBio's top domains

See how QuartzBio keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

quartz.bio1.81

See more with Sales Intelligence

QuartzBio top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by QuartzBio

These are the website technologies, by industry, used by QuartzBio top domains

Advertising (15)

Google Adsense

Payment & Currencies (8)

Cart Functionality

Email Services (6)

G Suite

Marketing (6)

Google Marketing Platform

More Technologies

11

See all

News & Signals from QuartzBio

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsEir Partners LLC invested into Quartzbio on May 13th '26.BALTIMORE, May 13, 2026 /PRNewswire/ - QuartzBio, a life science technology company delivering portfolio-scale sample and biomarker intelligence for clinical-stage biopharma, today announced a strategic growth investment and controlling interest from Eir Partners, a private equity firm focused on health tech and tech-enabled services.

NewsQuartzbio acquires Solve, Inc..FREDERICK, Md., Jan. 24, 2023 /PRNewswire/ -- Precision for Medicine, the first global, precision medicine clinical research services organization, today announced the strategic acquisition of SolveBio by QuartzBio.